Jefferies analyst Alan Spence upgrades Tenaris (NYSE:TS) from Hold to Buy and raises the price target from $35.7 to $46.
Legal Victory For Bayer: Roundup Lawsuit Ends Five-Trial Losing Streak
In a significant turn of events, Bayer AG (OTC: BAYRY) (OTC: BAYZF) emerged victorious in a California lawsuit filed by Bruce Jones, who alleged that the use of Roundup caused his non-Hodgkin lymphoma.&n
